Results 11 to 20 of about 13,758 (226)
Saudi Journal of Anaesthesia, 2023 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs).
Nilanjana Howbora +6 more
doaj +1 more source
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [PDF]
New England Journal of Medicine, 2018 (Abstracted from N Engl J Med 2018;378:230–240) The majority of patients with ovarian cancer (OC) receive an initial diagnosis of advanced disease that has spread from the ovaries to the peritoneal surface. The most effective treatment for patients with advanced disease is cytoreductive surgery followed by systemic chemotherapy.
Ceresoli, M, Frigerio, L, Ansaloni, L
openaire +17 more sources
BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]
, 2015 Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim +3 more
core +4 more sources
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2019 Objective: The aim of this study is to present our initial implementation experience in peritoneal carcinomatosis treatment and the technical details of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the light of current ...
Talgat Uskenbayev +4 more
doaj +1 more source
Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects
Креативная хирургия и онкология, 2021 Peritoneal carcinomatosis is viewed by many experts as a terminal illness with an unfavourable course and prognosis. Existing therapies are controversial and exhibit ambiguous efficacy.
Sh. Kh. Gantsev +3 more
doaj +1 more source
Gynecologic Oncology Reports, 2020 Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery ...
Nicholas K. Larsen +4 more
doaj +1 more source
International Journal of Hyperthermia, 2021 Purpose We aimed to determine the effects and possible mechanisms of hyperthermic intraperitoneal chemotherapy (HIPEC) in targeting ovarian cancer stem-like cells (CSCs).
Chao-Chih Wu +2 more
doaj +1 more source
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy [PDF]
Archives of Surgery, 2012 Until 2004, we treated peritoneal carcinomatosis with cytoreductive surgery accompanied by perioperative systemic chemotherapy. From October 2004, we decided to initiate a hyperthermic intraperitoneal chemotherapy (HIPEC) program for this condition.To determine the effect of HIPEC on postoperative outcomes at a single institution performing a high ...
Olivier, Turrini +6 more
openaire +2 more sources
Сибирский онкологический журнал, 2022 Gastric cancer (gc) is one of the most common cancers worldwide. The majority of newly diagnosed gastric cancer cases present with distant metastases. Peritoneal carcinomatosis (pc) is the most unfavorable type of progression of primary gc, which occurs ...
V. A. Markovich +10 more
doaj +1 more source
Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?
Clinical Medicine Insights: Oncology, 2021 Background: The number of cases of cervical cancer with recurrence and peritoneal carcinomatosis is limited. In our study, we aimed to present the results of cytoreductive surgery hyperthermic intraperitoneal chemotherapy treatment and its 3-year early ...
Ozgul Duzgun, Murat Kalin
doaj +1 more source